Selection of virtual product demonstrations & tours
3:40 pm Deep Dive LPS | Q&A
Speakers: Gerry Mackay, Fiona Coats
4:15 pm Sustainability at Sartorius | Q&A
Speakers: Joachim Kreuzburg, Katharina Tillmanns
4:45 pm
Closing of event
2 Sartorius & Sartorius Stedim Biotech Virtual Capital Markets Day 2021
Note
This presentation contains statements concerning the future performance of the Sartorius Group and Sartorius Stedim Biotech. These statements are based on assumptions and estimates. Although we are convinced that these forward-looking statements are realistic, we cannot guarantee that they will actually materialize. This is because our assumptions harbor risks and uncertainties that could lead to actual results diverging substantially from the expected ones. It is not planned to update our forward-looking statements.
Transcripts or recordings of this event are not permitted.
3 Sartorius & Sartorius Stedim Biotech Virtual Capital Markets Day 2021
Strategy & Financials
Joachim Kreuzburg, Rainer Lehmann | CMD 2021
Two divisions with a complementary focus on the life science market
Covering the entire biopharma value chain
Bioprocess Solutions Division
Molecule
Cell line
Production upstream
development
development
& downstream
Testing | Validation | Quality Control | Services
Lab Products & Services Division
Biopharma the increasingly dominating customer segment
~85%
Sales with life science| biopharma customers
~€2.3bn
24%
Lab Products
76%
& Services
Bioprocess
Solutions
5 Sartorius & Sartorius Stedim Biotech Virtual Capital Markets Day 2021
Attachments
Original document
Permalink
Disclaimer
Sartorius Stedim Biotech SA published this content on 25 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 May 2021 13:40:04 UTC.
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically.
For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis.
With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
SARTORIUS STEDIM BIOTECH 
